Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Seroma 1Neoplasms 1Breast Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Methylprednisolone Hemisuccinate × Clear all
NCT00903188 2009-05-18

CISTCERT

University Hospital, Antwerp

Phase 4 Unknown
152 enrolled
Tumor-Agnostic

Neoplasms

NCT00307606 2007-09-06

Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma

Herlev Hospital

Phase 4 Unknown
40 enrolled
Breast

Breast Neoplasms, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡